| Literature DB >> 35889250 |
Klaudia Stando1, Ewa Korzeniewska2, Ewa Felis3,4, Monika Harnisz2, Sylwia Bajkacz1,3.
Abstract
Manure is a major source of soil and plant contamination with veterinary drugs residues. The aim of this study was to evaluate the uptake of 14 veterinary pharmaceuticals by parsley from soil fertilized with manure. Pharmaceutical content was determined in roots and leaves. Liquid chromatography coupled with tandem mass spectrometry was used for targeted analysis. Screening analysis was performed to identify transformation products in the parsley tissues. A solid-liquid extraction procedure was developed combined with solid-phase extraction, providing recoveries of 61.9-97.1% for leaves and 51.7-95.6% for roots. Four analytes were detected in parsley: enrofloxacin, tylosin, sulfamethoxazole, and doxycycline. Enrofloxacin was detected at the highest concentrations (13.4-26.3 ng g-1). Doxycycline accumulated mainly in the roots, tylosin in the leaves, and sulfamethoxazole was found in both tissues. 14 transformation products were identified and their distribution were determined. This study provides important data on the uptake and transformation of pharmaceuticals in plant tissues.Entities:
Keywords: LC-MS/MS analysis; parsley; pharmaceuticals; plant metabolism; plant uptake; transformation products
Mesh:
Substances:
Year: 2022 PMID: 35889250 PMCID: PMC9317704 DOI: 10.3390/molecules27144378
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Figure 1Comparison of the efficiency of FCs’ extraction process following SLE-SPE procedure from parsley leaf.
Figure 2Comparison of efficiencies using SLE-SPE procedures for the separation of analytes from parsley root: SLE-SPE R1: McIlvaine buffer (pH = 4):ACN (1:1; v/v); SPE-SPE R2: McIlvaine buffer (pH = 4):MeOH (1:1; v/v); SLE-SPE R3: McIlvaine buffer (pH = 4):MeOH (1:1; v/v), McIlvaine buffer (pH = 4):ACN (1:1; v/v); SLE-SPE R4: McIlvaine buffer (pH = 4):ACN (1:1; v/v), 0.2 M NaOH:acetone (1:1; v/v); SLE-SPE R5: McIlvaine buffer (pH = 4):MeOH (1:1; v/v), 0.2 M NaOH:acetone (1:1; v/v); SLE-SPE R6: ACN: McIlvaine buffer (pH = 4):0.1 M EDTA (2:2:1; v/v/v).
Concentrations of selected pharmaceuticals in plant tissues.
| Concentration (ng·g−1 Dry Weight) (SD) | ||||||
|---|---|---|---|---|---|---|
| PMPA | BMPA | CP | ||||
| Tissues | leaf | root | leaf | root | leaf | root |
| TC | nd | nd | nd | nd | nd | nd |
| OTC | nd | nd | nd | nd | nd | nd |
| DOX | 2.1 (0.7) | 14.0 (0.5) | 3.0 (0.1) | 13.6 (4.4) | nd | nd |
| CIP | nd | nd | nd | nd | nd | nd |
| ENF | 23.9 (3.0) | 13.4 (0.5) | 29.3 (3.9) | 25.3 (3.7) | nd | nd |
| LVF | nd | nd | nd | nd | nd | nd |
| MET | nd | nd | nd | nd | nd | nd |
| CLR | nd | nd | nd | nd | nd | nd |
| CLD | nd | nd | nd | nd | nd | nd |
| SMX | 2.3 (0.1) | <LOQ | 2.3 (0.2) | 6.8 (2.2) | nd | nd |
| SFD | nd | nd | nd | nd | nd | nd |
| TYL | <LOQ | nd | <LOQ | nd | nd | nd |
| TRI | nd | nd | nd | nd | nd | nd |
| VAN | nd | nd | nd | nd | nd | nd |
PMPA-soil plots supplemented with poultry manure; BMPA-soil plots supplemented with bovine manure; CP-control plots without supplementation; nd–not detected.
Identified transformation products in parsley leaf and root samples.
| Lp. | TPs | PMPA | BMPA | CP | |||
|---|---|---|---|---|---|---|---|
| Leaf | Root | Leaf | Root | Leaf | Root | ||
| 1 | ENF263 | + | + | + | + | − | − |
| 2 | ENF330 | − | + | − | + | − | − |
| 3 | ENF390 | − | + | − | + | − | − |
| 4 | ENF282 | + | − | + | − | − | − |
| 5 | ENF342 | + | − | − | + | − | − |
| 6 | ENF376 | + | − | + | − | − | − |
| 7 | ENF334 | + | − | + | − | − | − |
| 8 | ENF306 | + | − | + | − | − | − |
| 9 | ENF223 | − | + | − | + | − | − |
| 10 | ENF291 | − | + | − | + | − | − |
| 11 | DOX274 | − | + | − | + | − | − |
| 12 | DOX399 | − | + | − | + | − | − |
| 13 | SMX158 | − | + | − | − | − | − |
| 14 | SMX216 | − | + | − | + | − | − |
Compilation of the determined pharmaceuticals and their identified transformation products.
| Analytes | Formula | [M + H]+
| Fragmentation Ions | Structure | Ref. |
|---|---|---|---|---|---|
| Pharmaceuticals | |||||
| DOX | C22H24N2O8 | 445.2 | 428.2 |
| [ |
| ENF | C19H22FN3O3 | 360.7 | 316.2 |
| |
| TYL | C46H77NO17 | 916.1 | 174.2 |
| |
| SMX | C10H11N3O3S | 253.9 | 92.0 |
| |
| Transformation products | |||||
| ENF263 | C13H11FN2O3 | 263.0 | 245.0 |
| [ |
| ENF330 | C17H19N3O4 | 330.0 | 312.0 |
| [ |
| ENF390 | C19H20FN3O5 | 390.0 | 372.0 |
| [ |
| ENF328 | C17H17N3O4 | 328.0 | 310.0 |
| [ |
| ENF342 | C19H23N3O3 | 342.0 | 324.0 |
| [ |
| ENF376 | C19H22FN3O4 | 376.1 | 358.1 |
| [ |
| ENF334 | C16H16FN3O4 | 334.0 | 316.0 |
| [ |
| ENF306 | C15H16FN3O3 | 306.9 | 288.0 |
| [ |
| ENF223 | C10H7FN2O3 | 223.0 | 207.0 |
| [ |
| ENF291 | C14H11FN2O4 | 291.0 | 273.0 |
| [ |
| DOX274 | C16H18O4 | 275.0 | 275.0 |
| [ |
| DOX399 | C21H21NO7 | 400.0 | 400.0 |
| [ |
| SMX158 | C6H7NO2S | 158.0 | 140.0 |
| [ |
| SMX216 | C7H9N3O3S | 216.0 | 156.0 |
| [ |